Application of 10343-06-3. Healthcare careers for chemists are once again largely based in laboratories, although increasingly there is opportunity to work at the point of care, helping with patient investigation. 10343-06-3, Name is 2,3,4,6-Tetra-o-acetyl-D-glucopyranose. In a document type is Patent, introducing its new discovery.
The invention discloses glucose derivative cationic liposome method for the preparation of nano-particles. Using glucose as the raw material, a series of different structure to synthesize the glucose derivative cationic lipid: Di -C 12-Glu-TMA, Di -C 12-Glu-TMA, Di -C 12-Glu-TMA, Di -C 12-Glu-TMA, Glu-DiC 12 MA, Glu-DiC 14 MA, Glu-DiC 16 MA and Glu-DiC 18 MA. The above-mentioned liposome through the water dispersion to obtain a good structure stability, moderate size particle size, particle size distribution is narrow, the surface charge is moderate, the preparation cost is low glucose derivative cationic liposome nanoparticle, can realize the nucleic acid drug from butcher outside to intracellular transit, can also be used for non-nucleate drug transfer carrier. (by machine translation)
If you are interested in 10343-06-3, you can contact me at any time and look forward to more communication.Application of 10343-06-3
Reference:
Tetrahydropyran – Wikipedia,
Tetrahydropyran – an overview | ScienceDirect Topics